Eagle Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US2697961082

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for ProQuest Associates IV LLC. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at ProQuest Associates IV LLC har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:URGN / UroGen Pharma Ltd. 10% Owner 1.242.031
US:EGRX / Eagle Pharmaceuticals, Inc. 10% Owner 149.107
US:AGRX / Agile Therapeutics, Inc. 10% Owner 5.062.363
US:IMDZ / Immune Design Corp. 10% Owner 1.983.858
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af ProQuest Associates IV LLC. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb EGRX / Eagle Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i EGRX / Eagle Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-02-18 EGRX ProQuest Associates IV LLC 333.333 15,0000 333.333 15,0000 4.999.995 365 36.7500 7.249.993 145,00

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
Insidersalg EGRX / Eagle Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i EGRX / Eagle Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2017-04-25 EGRX ProQuest Investments IV, L.P. 51.219 88,3400 51.219 88,3400 4.524.686 104 46.6200 -2.136.856 -47,23
2017-04-25 EGRX ProQuest Investments IV, L.P. 2.961 89,0900 2.961 89,0900 263.795
2017-04-03 EGRX ProQuest Investments IV, L.P. 61.420 83,1300 61.420 83,1300 5.105.845
2017-03-31 EGRX ProQuest Investments IV, L.P. 23.689 83,0200 23.689 83,0200 1.966.661
2017-03-30 EGRX ProQuest Investments IV, L.P. 6.223 83,0000 6.223 83,0000 516.509
2017-03-29 EGRX ProQuest Investments IV, L.P. 58.755 83,0100 58.755 83,0100 4.877.253
2017-03-29 EGRX ProQuest Investments IV, L.P. 500 83,0100 500 83,0100 41.505
2017-03-29 EGRX ProQuest Investments IV, L.P. 1.600 83,0100 1.600 83,0100 132.816
2017-03-28 EGRX ProQuest Investments IV, L.P. 6.182 83,0200 6.182 83,0200 513.230
2017-03-27 EGRX ProQuest Investments IV, L.P. 37.731 83,0000 37.731 83,0000 3.131.673
2017-03-27 EGRX ProQuest Investments IV, L.P. 400 83,0000 400 83,0000 33.200
2017-03-27 EGRX ProQuest Investments IV, L.P. 1.300 83,0000 1.300 83,0000 107.900
2017-03-23 EGRX ProQuest Investments IV, L.P. 700 83,0100 700 83,0100 58.107
2017-03-21 EGRX ProQuest Investments IV, L.P. 500 83,1000 500 83,1000 41.550
2017-03-20 EGRX ProQuest Investments IV, L.P. 51.883 82,1000 51.883 82,1000 4.259.594
2017-03-17 EGRX ProQuest Investments IV, L.P. 38.997 82,0100 38.997 82,0100 3.198.144
2017-03-16 EGRX ProQuest Investments IV, L.P. 9.120 82,0800 9.120 82,0800 748.570
2017-01-04 EGRX ProQuest Investments IV, L.P. 65.114 85,1600 65.114 85,1600 5.545.108
2016-11-11 EGRX ProQuest Investments IV, L.P. 15.551 85,0000 15.551 85,0000 1.321.835
2016-11-10 EGRX ProQuest Investments IV, L.P. 15.368 85,1000 15.368 85,1000 1.307.817
2016-11-10 EGRX ProQuest Investments IV, L.P. 167 86,0000 167 86,0000 14.362
2016-11-10 EGRX ProQuest Investments IV, L.P. 100 86,0600 100 86,0600 8.606
2016-11-10 EGRX ProQuest Investments IV, L.P. 1.700 87,0500 1.700 87,0500 147.985
2016-11-10 EGRX ProQuest Investments IV, L.P. 300 85,0000 300 85,0000 25.500
2016-11-10 EGRX ProQuest Investments IV, L.P. 1.300 85,0000 1.300 85,0000 110.500
2016-11-09 EGRX ProQuest Investments IV, L.P. 1.380 75,7000 1.380 75,7000 104.466
2016-11-09 EGRX ProQuest Investments IV, L.P. 11.690 76,4900 11.690 76,4900 894.168
2016-11-09 EGRX ProQuest Investments IV, L.P. 9.030 77,1300 9.030 77,1300 696.484
2016-11-09 EGRX ProQuest Investments IV, L.P. 4.200 78,2300 4.200 78,2300 328.566
2016-11-09 EGRX ProQuest Investments IV, L.P. 19.581 79,2400 19.581 79,2400 1.551.598
2016-11-09 EGRX ProQuest Investments IV, L.P. 102.919 80,0900 102.919 80,0900 8.242.783
2016-11-07 EGRX ProQuest Investments IV, L.P. 5.030 75,3900 5.030 75,3900 379.212
2016-11-04 EGRX ProQuest Investments IV, L.P. 46.170 75,0000 46.170 75,0000 3.462.750
2016-11-02 EGRX ProQuest Investments IV, L.P. 146.371 70,0000 146.371 70,0000 10.245.970
2016-11-02 EGRX ProQuest Investments IV, L.P. 50.329 70,4100 50.329 70,4100 3.543.665
2016-11-02 EGRX ProQuest Investments IV, L.P. 800 70,0000 800 70,0000 56.000
2016-11-02 EGRX ProQuest Investments IV, L.P. 2.100 70,0000 2.100 70,0000 147.000
2016-09-30 EGRX ProQuest Investments IV, L.P. 22.100 70,0600 22.100 70,0600 1.548.326
2016-09-29 EGRX ProQuest Investments IV, L.P. 77.900 70,0400 77.900 70,0400 5.456.116
2016-09-21 EGRX ProQuest Investments IV, L.P. 97.149 66,1500 97.149 66,1500 6.426.406
2016-09-21 EGRX ProQuest Investments IV, L.P. 1.798 67,2400 1.798 67,2400 120.898
2016-09-21 EGRX ProQuest Investments IV, L.P. 194 66,1700 194 66,1700 12.837
2016-09-21 EGRX ProQuest Investments IV, L.P. 654 66,1700 654 66,1700 43.275
2016-09-08 EGRX ProQuest Investments IV, L.P. 33.796 62,3300 33.796 62,3300 2.106.505
2016-09-08 EGRX ProQuest Investments IV, L.P. 66 62,3300 66 62,3300 4.114
2016-09-08 EGRX ProQuest Investments IV, L.P. 224 62,3300 224 62,3300 13.962
2016-09-07 EGRX ProQuest Investments IV, L.P. 11.345 62,2600 11.345 62,2600 706.340
2016-09-07 EGRX ProQuest Investments IV, L.P. 22 62,2600 22 62,2600 1.370
2016-09-07 EGRX ProQuest Investments IV, L.P. 75 62,2600 75 62,2600 4.670
2016-09-06 EGRX ProQuest Investments IV, L.P. 12.958 62,4500 12.958 62,4500 809.227
2016-09-06 EGRX ProQuest Investments IV, L.P. 12.224 63,2500 12.224 63,2500 773.168
2016-09-06 EGRX ProQuest Investments IV, L.P. 49 62,8300 49 62,8300 3.079
2016-09-06 EGRX ProQuest Investments IV, L.P. 166 62,8300 166 62,8300 10.430
2016-08-24 EGRX ProQuest Investments IV, L.P. 11.506 62,7800 11.506 62,7800 722.347
2016-08-24 EGRX ProQuest Investments IV, L.P. 23 62,7800 23 62,7800 1.444
2016-08-24 EGRX ProQuest Investments IV, L.P. 76 62,7800 76 62,7800 4.771
2016-08-23 EGRX ProQuest Investments IV, L.P. 17.118 63,1400 17.118 63,1400 1.080.831
2016-08-23 EGRX ProQuest Investments IV, L.P. 34 63,1200 34 63,1200 2.146
2016-08-23 EGRX ProQuest Investments IV, L.P. 113 63,1200 113 63,1200 7.133
2016-08-17 EGRX ProQuest Investments IV, L.P. 4.723 60,8500 4.723 60,8500 287.395
2016-08-17 EGRX ProQuest Investments IV, L.P. 9.848 61,1900 9.848 61,1900 602.599
2016-08-17 EGRX ProQuest Investments IV, L.P. 29 61,0000 29 61,0000 1.769
2016-08-17 EGRX ProQuest Investments IV, L.P. 96 61,0000 96 61,0000 5.856
2016-08-16 EGRX ProQuest Investments IV, L.P. 16.270 60,6600 16.270 60,6600 986.938
2016-08-16 EGRX ProQuest Investments IV, L.P. 11.770 61,6500 11.770 61,6500 725.620
2016-08-16 EGRX ProQuest Investments IV, L.P. 31.599 62,2100 31.599 62,2100 1.965.774
2016-08-16 EGRX ProQuest Investments IV, L.P. 117 60,7800 117 60,7800 7.111
2016-08-16 EGRX ProQuest Investments IV, L.P. 394 60,7800 394 60,7800 23.947
2016-08-15 EGRX ProQuest Investments IV, L.P. 16.667 60,5100 16.667 60,5100 1.008.520
2016-08-15 EGRX ProQuest Investments IV, L.P. 8.070 61,3100 8.070 61,3100 494.772
2016-08-15 EGRX ProQuest Investments IV, L.P. 49 60,7000 49 60,7000 2.974
2016-08-15 EGRX ProQuest Investments IV, L.P. 163 60,7000 163 60,7000 9.894
2016-05-13 EGRX ProQuest Management LLC 13.980 40,9200 13.980 40,9200 572.062
2016-05-12 EGRX ProQuest Management LLC 4.000 40,0000 4.000 40,0000 160.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
Insiderkøb URGN / UroGen Pharma Ltd. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i EGRX / Eagle Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

URGN / UroGen Pharma Ltd. Insider Trades
Insidersalg URGN / UroGen Pharma Ltd. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i EGRX / Eagle Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2017-11-28 URGN ProQuest Investments IV, L.P. 177.807 40,5100 177.807 40,5100 7.202.962 15 36.8000 -659.663 -9,16
2017-11-27 URGN ProQuest Investments IV, L.P. 31.491 41,1200 31.491 41,1200 1.294.910

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

URGN / UroGen Pharma Ltd. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af ProQuest Associates IV LLC som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2017-11-29 2017-11-28 4 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
S - Sale -177.807 1.242.031 -12,52 40,51 -7.202.962 50.314.676
2017-11-29 2017-11-27 4 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
S - Sale -31.491 1.419.838 -2,17 41,12 -1.294.910 58.383.739
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-07-20 3 URGN UroGen Pharma Ltd.
Ordinary Shares, par value NIS 0.01 per share
2.902.658
2017-05-15 2017-05-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
J - Other 149.107 149.107
2017-05-15 2017-05-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
J - Other 149.107 162.661 1.100,10
2017-05-15 2017-05-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
J - Other -3.584.087 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -20.000 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -9.360 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -3.120 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.340 0 -100,00
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -2.961 6.777 -30,41 89,09 -263.795 603.763
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -51.219 9.738 -84,02 88,34 -4.524.686 860.255
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 20.000 60.957 48,83 59,31 1.186.200 3.615.360
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 10.000 40.957 32,30 46,09 460.900 1.887.708
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 9.360 30.957 43,34 12,67 118.591 392.225
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 3.120 21.597 16,89 4,42 13.790 95.459
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 18.477 14,50 8,78 20.545 162.228
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 10.840.560 0,02 8,78 20.545 95.180.117
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 18.477 14,50 8,78 20.545 162.228
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 11.457 25,67 4,04 9.454 46.286
2017-04-27 2017-04-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
M - Exercise 2.340 9.117 34,53 0,90 2.106 8.205
2017-04-03 2017-04-03 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -61.420 3.584.087 -1,68 83,13 -5.105.845 297.945.152
2017-04-03 2017-03-31 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -23.689 3.645.507 -0,65 83,02 -1.966.661 302.649.991
2017-04-03 2017-03-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -6.223 3.669.196 -0,17 83,00 -516.509 304.543.268
2017-03-29 2017-03-29 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.600 23.274 -6,43 83,01 -132.816 1.931.975
2017-03-29 2017-03-29 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -500 6.777 -6,87 83,01 -41.505 562.559
2017-03-29 2017-03-29 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -58.755 3.675.419 -1,57 83,01 -4.877.253 305.096.531
2017-03-29 2017-03-28 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -6.182 3.734.174 -0,17 83,02 -513.230 310.011.125
2017-03-29 2017-03-27 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.300 24.874 -4,97 83,00 -107.900 2.064.542
2017-03-29 2017-03-27 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -400 7.277 -5,21 83,00 -33.200 603.991
2017-03-29 2017-03-27 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -37.731 3.740.356 -1,00 83,00 -3.131.673 310.449.548
2017-03-23 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -700 3.778.087 -0,02 83,01 -58.107 313.619.002
2017-03-23 2017-03-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -500 3.778.787 -0,01 83,10 -41.550 314.017.200
2017-03-20 2017-03-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -51.883 3.779.287 -1,35 82,10 -4.259.594 310.279.463
2017-03-20 2017-03-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
S - Sale -38.997 3.831.170 -1,01 82,01 -3.198.144 314.194.252
2017-03-20 2017-03-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -9.120 3.870.167 -0,24 82,08 -748.570 317.663.307
2017-01-06 2017-01-04 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -65.114 3.879.287 -1,65 85,16 -5.545.108 330.360.081
2016-11-14 2016-11-11 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -15.551 3.944.401 -0,39 85,00 -1.321.835 335.274.085
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.300 26.174 -4,73 85,00 -110.500 2.224.790
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -300 7.677 -3,76 85,00 -25.500 652.545
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.700 3.959.952 -0,04 87,05 -147.985 344.713.822
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -100 3.961.652 0,00 86,06 -8.606 340.939.771
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -167 3.961.752 0,00 86,00 -14.362 340.710.672
2016-11-14 2016-11-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -15.368 3.961.919 -0,39 85,10 -1.307.817 337.159.307
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -102.919 3.977.287 -2,52 80,09 -8.242.783 318.540.916
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -19.581 4.080.206 -0,48 79,24 -1.551.598 323.315.523
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -4.200 4.099.787 -0,10 78,23 -328.566 320.726.337
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -9.030 4.103.987 -0,22 77,13 -696.484 316.540.517
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -11.690 4.113.017 -0,28 76,49 -894.168 314.604.670
2016-11-09 2016-11-09 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.380 4.124.707 -0,03 75,70 -104.466 312.240.320
2016-11-09 2016-11-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -5.030 4.126.087 -0,12 75,39 -379.212 311.065.699
2016-11-04 2016-11-04 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -46.170 4.181.446 -1,09 75,00 -3.462.750 313.608.450
2016-11-04 2016-11-02 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -2.100 27.474 -7,10 70,00 -147.000 1.923.180
2016-11-04 2016-11-02 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -800 7.977 -9,11 70,00 -56.000 558.390
2016-11-04 2016-11-02 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -50.329 4.177.287 -1,19 70,41 -3.543.665 294.122.778
2016-11-04 2016-11-02 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -146.371 4.227.616 -3,35 70,00 -10.245.970 295.933.120
2016-10-04 2016-09-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -22.100 4.373.987 -0,50 70,06 -1.548.326 306.441.529
2016-09-30 2016-09-29 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -77.900 4.396.087 -1,74 70,04 -5.456.116 307.901.933
2016-09-23 2016-09-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -654 29.574 -2,16 66,17 -43.275 1.956.912
2016-09-23 2016-09-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -194 8.777 -2,16 66,17 -12.837 580.774
2016-09-23 2016-09-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -1.798 4.473.987 -0,04 67,24 -120.898 300.830.886
2016-09-23 2016-09-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -97.149 4.475.785 -2,12 66,15 -6.426.406 296.073.178
2016-09-08 2016-09-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -224 30.228 -0,74 62,33 -13.962 1.884.111
2016-09-08 2016-09-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -66 8.971 -0,73 62,33 -4.114 559.162
2016-09-08 2016-09-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -33.796 4.572.934 -0,73 62,33 -2.106.505 285.030.976
2016-09-08 2016-09-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -75 30.452 -0,25 62,26 -4.670 1.895.942
2016-09-08 2016-09-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -22 9.037 -0,24 62,26 -1.370 562.644
2016-09-08 2016-09-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -11.345 4.606.730 -0,25 62,26 -706.340 286.815.010
2016-09-08 2016-09-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -166 30.527 -0,54 62,83 -10.430 1.918.011
2016-09-08 2016-09-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -49 9.059 -0,54 62,83 -3.079 569.177
2016-09-08 2016-09-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -12.224 4.618.075 -0,26 63,25 -773.168 292.093.244
2016-09-08 2016-09-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -12.958 4.630.299 -0,28 62,45 -809.227 289.162.173
2016-08-25 2016-08-24 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -76 30.693 -0,25 62,78 -4.771 1.926.907
2016-08-25 2016-08-24 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -23 9.108 -0,25 62,78 -1.444 571.800
2016-08-25 2016-08-24 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -11.506 4.643.257 -0,25 62,78 -722.347 291.503.674
2016-08-25 2016-08-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -113 30.769 -0,37 63,12 -7.133 1.942.139
2016-08-25 2016-08-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -34 9.131 -0,37 63,12 -2.146 576.349
2016-08-25 2016-08-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -17.118 4.654.763 -0,37 63,14 -1.080.831 293.901.736
2016-08-17 2016-08-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -96 30.882 -0,31 61,00 -5.856 1.883.802
2016-08-17 2016-08-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -29 5.387 -0,54 61,00 -1.769 328.607
2016-08-17 2016-08-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -9.848 4.671.779 -0,21 61,19 -602.599 285.866.157
2016-08-17 2016-08-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -4.723 4.681.627 -0,10 60,85 -287.395 284.877.003
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -394 30.978 -1,26 60,78 -23.947 1.882.843
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -117 5.416 -2,11 60,78 -7.111 329.184
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -31.599 4.686.350 -0,67 62,21 -1.965.774 291.537.834
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -11.770 4.717.949 -0,25 61,65 -725.620 290.861.556
2016-08-17 2016-08-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -16.270 4.729.719 -0,34 60,66 -986.938 286.904.755
2016-08-17 2016-08-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -163 31.372 -0,52 60,70 -9.894 1.904.280
2016-08-17 2016-08-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
S - Sale -49 5.533 -0,88 60,70 -2.974 335.853
2016-08-17 2016-08-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0.001 par value
S - Sale -8.070 4.745.989 -0,17 61,31 -494.772 290.976.586
2016-08-17 2016-08-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
S - Sale -16.667 4.754.059 -0,35 60,51 -1.008.520 287.668.110
2016-06-30 2016-06-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
J - Other -9.903 5.582 -63,95
2016-05-24 2016-05-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
J - Other -9.360 9.360 -50,00
2016-05-24 2016-05-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
J - Other -4.770.828 4.770.828 -50,00
2016-05-16 2016-05-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock $0,001 par value
S - Sale -13.980 41.081 -25,39 40,92 -572.062 1.681.035
2016-05-16 2016-05-12 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
S - Sale -4.000 55.061 -6,77 40,00 -160.000 2.202.440
2016-01-29 2016-01-27 4 AGRX AGILE THERAPEUTICS INC
Common Stock
P - Purchase 393.700 5.062.363 8,43 6,35 2.499.995 32.146.005
2015-07-02 2015-07-01 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
J - Other -2.970 59.061 -4,79
2015-05-13 2015-05-12 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -155.000 1.983.858 -7,25 21,50 -3.332.500 42.652.947
2015-05-13 2015-05-12 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -22.607 2.138.858 -1,05 22,26 -503.232 47.610.979
2015-05-07 2015-05-06 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
J - Other -9.903 62.031 -13,77
2015-04-24 2015-04-24 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -25.000 2.161.465 -1,14 26,64 -666.000 57.581.428
2015-04-24 2015-04-23 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -22.643 2.186.465 -1,02 27,35 -619.286 59.799.818
2015-04-24 2015-04-23 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -10.000 2.209.108 -0,45 26,64 -266.400 58.850.637
2015-04-24 2015-04-22 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -25.249 2.219.108 -1,12 26,56 -670.613 58.939.508
2015-04-21 2015-04-21 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -14.167 2.244.357 -0,63 26,35 -373.300 59.138.807
2015-04-21 2015-04-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -12.792 2.258.524 -0,56 26,44 -338.220 59.715.375
2015-04-21 2015-04-17 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -18.861 2.271.316 -0,82 26,67 -503.023 60.575.998
2015-04-16 2015-04-16 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.290.177 0,00 26,75 -2.675 61.262.235
2015-04-16 2015-04-15 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.290.277 0,00 29,17 -2.917 66.807.380
2015-04-16 2015-04-15 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -39.900 2.290.377 -1,71 28,57 -1.139.943 65.436.071
2015-04-16 2015-04-14 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -13.814 2.330.277 -0,59 27,26 -376.570 63.523.351
2015-04-08 2015-04-07 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -3.600 2.344.091 -0,15 26,55 -95.580 62.235.616
2015-04-08 2015-04-06 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -3.895 2.347.691 -0,17 26,88 -104.698 63.105.934
2015-04-02 2015-04-01 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -8.035 2.351.586 -0,34 27,07 -217.507 63.657.433
2015-04-02 2015-04-01 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -39.819 2.359.621 -1,66 26,55 -1.057.194 62.647.938
2015-04-02 2015-04-01 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -14.600 2.399.440 -0,60 25,51 -372.446 61.209.714
2015-03-26 2015-03-25 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -4.956 2.414.040 -0,20 27,56 -136.587 66.530.942
2015-03-26 2015-03-24 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -13.200 2.418.996 -0,54 27,67 -365.244 66.933.619
2015-03-23 2015-03-23 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -5.000 2.432.196 -0,21 27,78 -138.900 67.566.405
2015-03-23 2015-03-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -84 2.437.196 0,00 28,15 -2.365 68.607.067
2015-03-23 2015-03-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -400 2.437.280 -0,02 28,13 -11.252 68.560.686
2015-03-23 2015-03-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -200 2.437.680 -0,01 28,04 -5.608 68.352.547
2015-03-23 2015-03-20 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -8.780 2.437.880 -0,36 27,19 -238.749 66.291.808
2015-03-23 2015-03-19 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -200 2.446.660 -0,01 28,07 -5.614 68.677.746
2015-03-23 2015-03-19 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -29.800 2.446.860 -1,20 27,55 -820.990 67.410.993
2015-03-18 2015-03-18 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.476.660 0,00 27,02 -2.702 66.919.353
2015-03-18 2015-03-18 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -500 2.476.760 -0,02 26,99 -13.495 66.847.752
2015-03-18 2015-03-18 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.477.260 0,00 27,04 -2.704 66.985.110
2015-03-18 2015-03-18 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -19.300 2.477.360 -0,77 26,56 -512.608 65.798.682
2015-03-18 2015-03-17 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -20.000 2.496.660 -0,79 25,94 -518.800 64.763.360
2015-03-18 2015-03-16 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -10.309 2.516.660 -0,41 25,43 -262.158 63.998.664
2015-03-12 2015-03-12 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -94.199 2.526.969 -3,59 24,94 -2.349.323 63.022.607
2015-03-12 2015-03-11 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -29.000 2.621.168 -1,09 25,02 -725.580 65.581.623
2015-03-12 2015-03-10 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -6.143 2.650.168 -0,23 24,65 -151.425 65.326.641
2015-03-09 2015-03-09 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -32.300 2.656.311 -1,20 25,61 -827.203 68.028.125
2015-03-09 2015-03-06 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -100 2.688.611 0,00 25,02 -2.502 67.269.047
2015-03-09 2015-03-06 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -1.046 2.688.711 -0,04 25,00 -26.150 67.217.775
2015-03-09 2015-03-05 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -6.000 2.689.757 -0,22 24,65 -147.900 66.302.510
2015-01-23 2015-01-23 4 AGRX AGILE THERAPEUTICS INC
Common Stock
P - Purchase 811.966 4.668.663 21,05 5,85 4.750.001 27.311.679
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -305.810 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
X - Other 305.810 305.810
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock Warrant (right to buy)
X - Other -305.810 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -611.620 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series B Preferred Stock
C - Conversion -1.595.530 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 391.131 2.695.757 16,97 12,00 4.693.572 32.349.084
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
S - Sale -208.334 2.304.626 -8,29 12,00 -2.500.008 27.655.512
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 305.810 2.512.960 13,86
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 611.620 2.207.150 38,33
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 1.595.530 1.595.530
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Series A-1 Preferred Stock
C - Conversion -117.441 0 -100,00
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Convertible Subordinated Notes
C - Conversion
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Warrants (right to buy)
J - Other -141.825 0 -100,00
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Series C Preferred Stock
C - Conversion -328.821 0 -100,00
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Series B Preferred Stock
C - Conversion -1.393.000 0 -100,00
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
P - Purchase 1.120.833 3.856.697 40,97 6,00 6.724.998 23.140.182
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
C - Conversion 158.174 2.735.864 6,14 6,00 949.044 16.415.184
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
C - Conversion 460.350 2.577.690 21,74
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
C - Conversion 1.950.200 2.117.340 1.166,81
2014-06-02 2014-05-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock
C - Conversion 164.417 167.140 6.038,08
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-05-22 3 AGRX AGILE THERAPEUTICS INC
Common Stock
5.446
2014-04-17 2014-02-18 4/A EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 9.359 71.934 14,96
2014-04-17 2014-02-18 4/A EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 62.575 62.575
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series C Warrants
X - Other -1.614 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -9.359 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series B-1 Convertible Preferred Stock
C - Conversion -62.575 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series C Warrants
X - Other -98.368 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -569.538 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series B-1 Convertible Preferred Stock
C - Conversion -850.520 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -1.028.613 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -1.927.986 0 -100,00
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
X - Other 357 72.291 0,50
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 9.359 72.291 14,87
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 62.575 71.934 668,61
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
P - Purchase 333.333 4.770.828 7,51 15,00 4.999.995 71.562.420
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
X - Other 21.837 4.437.495 0,49
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 569.538 4.415.658 14,81
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 850.520 3.846.120 28,39
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 1.028.616 2.995.600 52,29
2014-02-20 2014-02-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
C - Conversion 1.927.986 1.966.987 4.943,43
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common stock, $0.001 par value
87.362
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
57.721
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common stock, $0.001 par value
87.362
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
57.721
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common stock, $0.001 par value
87.362
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
57.721
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common stock, $0.001 par value
87.362
2014-02-11 3 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock, $0.001 par value
57.721
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)